Analysts are continuing to downgrade shares of the now-battered Arena Pharma (Nasdaq: ARNA) this week. The company's stock tumbled by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE